title: [Complete remission of Crohn's disease after high-dose alpha-interferon treatment for malignant melanoma].
authors.affiliation: Servicio de Gastroenterología, Hospital Universitario Ramón y Cajal, Madrid, España. Electronic address: c_ferre_a@hotmail.com.
authors.forename: Carlos
authors.initials: C
authors.lastname: Ferre Aracil
authors.affiliation: Servicio de Gastroenterología, Hospital Universitario Ramón y Cajal, Madrid, España.
authors.forename: Enrique
authors.initials: E
authors.lastname: Rodríguez de Santiago
authors.affiliation: Servicio de Gastroenterología, Hospital Universitario Ramón y Cajal, Madrid, España.
authors.forename: Ana
authors.initials: A
authors.lastname: García García de Paredes
authors.affiliation: Servicio de Gastroenterología, Hospital Universitario Ramón y Cajal, Madrid, España.
authors.forename: Lara
authors.initials: L
authors.lastname: Aguilera Castro
authors.affiliation: Servicio de Oncología Médica, Hospital Universitario Ramón y Cajal, Madrid, España.
authors.forename: Ainara
authors.initials: A
authors.lastname: Soria Rivas
authors.affiliation: Servicio de Gastroenterología, Hospital Universitario Ramón y Cajal, Madrid, España.
authors.forename: Antonio
authors.initials: A
authors.lastname: López SanRomán
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003424:Crohn Disease / Q000150:complications* / Q000188:drug therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D008545:Melanoma / Q000150:complications / Q000188:drug therapy* / Q000601:surgery; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D012074:Remission Induction; D012878:Skin Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000601:surgery
chemical_list: D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins